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A B S T R A C T
Ovine parasitic gastroenteritis is a complex disease routinely treated using anthelmintics. Although many dif-
ferent strongyle species may contribute to parasitic gastroenteritis, not all are equally pathogenic: in temperate
regions, the primary pathogen is Teladorsagia circumcincta. In this study we investigated benzimidazole and
ivermectin resistance on a commercial sheep farm in southeast Scotland. We assessed the impact of species
diversity on the diagnosis of resistance using the faecal egg count reduction test and in vitro bioassays, and
correlated the results with the frequency of benzimidazole resistance-associated genotypes measured in the T.
circumcincta population by pyrosequencing of the β-tubulin isotype-1 gene.
Faecal egg count reduction test results showed efficacies of 65% for albendazole and 77% for ivermectin,
indicating moderate resistance levels on the farm. However, PCR speciation of the same populations pre- and
post-treatment revealed that removal of susceptible species had masked the presence of a highly resistant po-
pulation of T. circumcincta. Less than 25% of individuals in the pre-treatment populations were T. circumcincta,
the remainder consisting of Cooperia curticei, Chabertia ovina, Oesophagostomum venulosum and Trichostrongylus
spp. In contrast, post-treatment with albendazole or ivermectin, the majority (88% and 100% respectively) of the
populations consisted of T. circumcincta. The egg hatch test for benzimidazole resistance and the larval devel-
opment test for ivermectin resistance were carried out using eggs obtained from the same populations and the
results were broadly consistent with the faecal egg count reduction test. Thirty individual T. circumcincta from
each sampling time point were assessed for benzimidazole resistance by pyrosequencing, revealing a high fre-
quency and diversity of resistance-associated mutations, including within the population sampled post-iver-
mectin treatment.
These results highlight the potential diversity of parasite species present on UK farms, and their importance in
the diagnosis of anthelmintic resistance. On this particular farm, we demonstrate the presence of a highly dual-
resistant population of T. circumcincta, which was strongly selected by treatment with either benzimidazoles or
ivermectin, while other potentially less pathogenic species were removed.
1. Introduction
Parasitic gastroenteritis (PGE) is ubiquitous on UK sheep farms and
is a significant production limiting disease (Sargison, 2011), resulting in
poor weight gain, diarrhoea, dehydration, anaemia and death (Durham
and Elliott, 1975). PGE is a complex disease, influenced by many host
and management factors and caused by a diverse range of strongyle
species (Burgess et al., 2012), of which Teladorsagia circumcincta pre-
dominates during the UK summer. The clinical diagnosis in live animals
is underpinned by faecal egg counts (FECs) to detect and enumerate
strongyle eggs.
Broad-spectrum anthelmintics, including benzimidazoles (BZ) and
ivermectin (IVM), are used to treat PGE but resistance is widespread
(Kaplan and Vidyashankar, 2012). Two recent studies in Wales and
Northern Ireland found between 81 and 94% of farms tested had BZ
resistance and 50–51% had IVM resistance (McMahon et al., 2013;
Hybu Cig Cymru (HCC), 2015). In practice, anthelmintic efficacy is
determined using a faecal egg count reduction test (FECRT). This in-
volves faecal sampling a group of animals pre- and post-treatment
(Coles et al., 2006), or comparison of a post-treatment group with a
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control group (Coles et al., 1992). The reduction in strongyle FEC is
calculated to determine the anthelmintic efficacy. If the reduction is less
than 95%, and the lower 95% confidence interval is less than 90%,
anthelmintic resistance is diagnosed (Coles et al., 1992).
The FECRT is a straightforward and useful test, but it has limita-
tions. FECRTs depend on a reduction in strongyle eggs, but these gen-
erally consist of a mixed population of strongyle species. Importantly,
not all strongyles are considered equally pathogenic in sheep (Crilly and
Sargison, 2015), and not all species on a holding are necessarily drug
resistant (McKenna, 1997; McMahon et al., 2013; Melville et al., 2016).
The FECRT also lacks sensitivity if resistant phenotypes comprise less
than 25% of the population (Martin et al., 1989). This phenomenon has
been noted in the disparity between BZ resistance genotypes detected
by PCR and FECRT results (Kaplan and Vidyashankar, 2012). BZ re-
sistance is associated with non-synonymous single nucleotide poly-
morphisms (SNPs) within the β-tubulin isotype-1 gene, which appear
conserved within and between strongyle species and can be detected by
PCR or pyrosequencing (Kwa et al., 1995; Silvestre and Cabaret, 2002;
Ghisi et al., 2007; Redman et al., 2015). Molecular tests are highly
sensitive and specific, but are only currently available for BZ resistance.
While laboratory bioassays for anthelmintic resistance are a possible
alternative, they are time consuming and can be technically challenging
in mixed species infections.
This study describes a FECRT undertaken on a commercial sheep
farm in southeast Scotland to compare BZ and IVM resistance status
detected in the field, combined with in vitro phenotypic bioassays and
pyrosequencing of the β-tubulin isotype-1 gene. The results highlight
the importance of parasite species composition in the interpretation of
FECRTs and in the design of appropriate and sustainable control stra-
tegies.
2. Materials and methods
2.1. Study Farm
A lowland sheep farm in southeast Scotland was visited in
September 2016, with the agreement of the shepherd and previous
knowledge of the presence of anthelmintic resistance (Wilson et al.,
2008; Sargison et al., 2012). Each year in the autumn, a proportion of
the breeding flock was replaced with bought in ewe lambs. Sheep were
able to graze rented pastures, which were also leased to neighbouring
sheep farms. In addition, cattle occasionally grazed farm pastures,
though had not done so in the last two years. Moxidectin is used rou-
tinely at lambing time, with most twin-bearing ewes treated and some
triplet- or single-bearing ewes also treated. BZs are used to control
Nematodirus battus in the lambs, with three treatments used in the year
of study. Further anthelmintics are used to control summer PGE in the
lambs, and rams are dosed periodically with anthelmintics. Table 1
shows the anthelmintics given during the year of study.
2.2. Faecal egg count reduction test
Thirty-five, five-and-a-half month old lambs were set aside by the
farmer and from these, animals were selected randomly for use in the
FECRT. Faeces were collected per rectum for FECs pre-treatment, with
additional material gathered for further analysis, if voided immediately
following treatment. Ten lambs were allocated to the albendazole (BZ)
treatment group (5mg/kg body weight (BW), Albex™ 2.5% w/v SC oral
suspension (Chanelle UK)) and twelve lambs to the IVM treatment
group (0.2 mg/kg BW, Noromectin® 0.08% w/v Drench Oral Solution
(Norbrook)). Lambs were identified to their group but not individually.
All were weighed individually, using the shepherd’s weigh scales (EID
weigh crate, Shearwell), and dosed per os according to their individual
weights using a syringe. Repeat faecal samples were collected on days 7
and 14 post-treatment and faeces transferred anaerobically to the la-
boratory.
A cuvette method, sensitive to 1 egg per gram (epg) (Christie and
Jackson, 1982) was used for the FECs. Briefly, faeces were weighed and
water was added in a ratio of 10ml to 1 g, following which 10ml was
strained through a coarse sieve (1mm aperture). After centrifugation at
234×g for 2min, the supernatant was aspirated and the egg pellet re-
suspended in saturated sodium chloride solution (specific gravity 1.2)
with a further centrifugation step (as above). The meniscus was isolated
using artery forceps and tipped into a cuvette, which was filled with
saturated NaCl solution for counting. Strongyle egg counts were ana-
lysed using Minitab (Minitab® 17.1.0, Microsoft). Group arithmetic
means were calculated, with 95% confidence intervals (CIs). Differ-
ences between medians of sample groups were assessed for significance
by a Mann-Whitney test. The FECR percentage and Bayesian CIs were
calculated using R Shiny ‘eggCounts’ web interface (Wang and Paul,
2017; Wang et al., 2017).
2.3. Bioassays
Strongyle eggs were harvested for immediate use in bioassays
(within three hours of faecal collection) as described in 2.2, but with
the following modifications; emulsified faeces were strained through a
series of sieves, (215 μm, 125 μm and 63 μm), with eggs collected from
a 38 μm sieve. Centrifugation steps were performed as described above,
and the meniscus was poured back onto a small, 38 μm sieve. Eggs were
washed with tap water to remove salt and collected. A 200 μl aliquot of
egg suspension was counted, using the cuvette method, to determine
the total number of eggs/ml. The egg concentration was adjusted to 1
egg/μl for the egg hatch test (EHT) and 2 eggs/μl for the larval devel-
opment test (LDT).
2.3.1. Egg hatch test
An EHT was set up to measure BZ efficacy, essentially as described
previously (Coles et al., 2006). Stock solutions of TBZ were prepared by
diluting 1mg/ml of TBZ/DMSO solution into DMSO and were stored in
opaque tubes. Briefly, a 24 well plate was set up with a range of final
TBZ concentrations as follows: 0.05 μg/ml, 0.1 μg/ml, 0.2 μg/ml,
0.3 μg/ml, 0.4 μg/ml, 0.5 μg/ml, 1 μg/ml and 0.5% DMSO control
(Sigma Aldrich). To each well was added: 10 μl of TBZ/DMSO solution,
1890 μl deionised water (Acros Organics) and 100 μl of egg suspension,
giving approximately 100 eggs/well.
Four EHTs were performed using pre-treatment samples for each of
the BZ and IVM treated lamb groups. For each of the eight tests, all
concentrations were repeated in triplicate, when sufficient eggs were
available. Plates were incubated in a humid environment at 25 °C for
48 h and the number of unhatched eggs and first stage larvae (L1) re-
corded at 48 h.
On day 14 post-treatment a reduced EHT was performed for the BZ
treated population as follows: all TBZ concentrations were incorporated
but a reduced quantity of eggs restricted replicate numbers. Two re-
plicates were carried out for each of 0.05 μg/ml, 0.1 μg/ml and 0.2 μg/
Table 1
Anthelmintics administered during the year 2016 from lambing until all lambs
were sold.
Date of treatment Anthelmintic Treatment group
1st April onwards – at
lambing
Moxidectin Lambed ewes
23/05/16 Albendazole Lambs
14/06/16 Albendazole Lambs
01/07/16 Ivermectin Rams
06/07/16 Albendazole Lambs
20/09/16 Levamisole Lambs
20/09/16 FECRT – albendazole or
ivermectin
Two groups of lambs
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ml. The rest were single wells. Due to a paucity of eggs post-IVM
treatment of lambs, it was not possible to perform a full EHT and only
two replicates of the ‘definitive dose’ wells (0.1 μg/ml) were included.
The ED50, the effective dose at which 50% of larvae fail to hatch,
was calculated using a binomial (probit) general linear model (GLM) in
R Studio (version 1.1.383 – © 2009–2017 RStudio, Inc; R version 3.4.3
© 2017). All data were first corrected for the percentage hatch in the
DMSO control wells and the TBZ concentrations were log10 trans-
formed. If the ED50 was greater than 0.1 μg/ml TBZ, then the sample
population was considered resistant to BZ (Coles et al., 1992; von
Samson-Himmelstjerna et al., 2009).
2.3.2. Larval development test
The LDT was performed on strongyle populations obtained pre- and
post-IVM treatment (day 0 and day 14) and pre-BZ treatment.
Insufficient eggs were recovered post-BZ treatment to allow a LDT to be
carried out. A method adapted from Varady et al (1996) was used to
ascertain the ability of larvae to develop in the following concentrations
of IVM: 0.57 nM, 1.14 nM, 2.29 nM, 4.54 nM, 9.14 nM, 18.29 nM and
36.58 nM, water only (control), and 2% DMSO (control). Stock solu-
tions of IVM (Catalogue number I8898, Sigma Aldrich) were prepared
by diluting a 0.001M IVM/DMSO solution into DMSO and were stored
in opaque tubes. Briefly, a 48 well plate was set up, each well con-
taining 6 μl of IVM/DMSO solution, 239 μl deionised water and 5 μl of a
highly concentrated, reconstituted, lyophilised E. coli OP50 as a food
source for the developing larvae (Heim et al., 2015). 50 μl of strongyle
eggs were added (concentration of 2 eggs/μl), giving approximately
100 eggs/well. No antimicrobials were used. Wells surrounding those
used for the assay were filled with deionised water and the plate sealed
with an adhesive plastic seal (Sigma Aldrich). The plate lid was re-
placed and the assay incubated for 7 days at 25 °C in a humid en-
vironment. Eggs, L1/L2 and L3 larvae were counted. Following cor-
rection for development in the control wells, an ED50 for each sample
was calculated using a general linear model (GLM) constructed in R
Studio as above.
2.4. Molecular biology
2.4.1. Lysates
Lysates were made from individual strongyle eggs, L1 or infective
larvae (L3) in 96 well plates from all sampling time points. On day 0
and day 7 post-treatment, L3 from coproculture were used. On day 14
post-treatment, eggs and L1 from EHTs were used. Briefly, a master mix
per 100 wells was prepared as follows: 1000 μl DirectPCR Lysis Reagent
(Cell; Viagen Biotech), 50 μl 1 M DTT (Thermofisher Scientific) and
10 μl Proteinase K (Fungal; Invitrogen) at 100mg/ml in DEPC treated
water (Ambion). 10 μl was dispensed per well and a single egg or larva
added to each in≤ 1 μl of water/PCR Lysis Reagent. After incubation at
60 °C for 2 h, followed by 85 °C for 45min to denature the proteinase K,
lysates were aliquoted in 1:20 dilutions using DEPC treated water. All
lysates were stored at −80 °C.
2.4.2. Speciation of strongyles by PCR
Individual eggs, L1 or L3, harvested as described in 2.4.1, were
identified by PCR to species level using the ITS2 region (Wimmer et al.,
2004; Redman et al., 2008; Burgess et al., 2012; Bisset et al., 2014).
Strongyle numbers speciated were as follows: for the BZ FECRT on day
0, 96 L3, on day 7, 62 L3 and on day 14, 82 eggs or L1. For the IVM
FECRT on day 0, 83 L3 were speciated, on day 7, 83 L3 and on day 14,
42 eggs or L1. Two PCR methods were employed. Briefly, single species
PCR was performed using GoTaq Flexi polymerase (Promega) according
to the manufacturer’s instructions. The total volume of each reaction
was 12.5 μl of which 1 μl was 1:20 DNA lysate. Primers designed to
amplify the ITS2 region and specific to the species of interest were used.
Table 2 shows primer sequences with their original reference, expected
amplicon size, and TA °C. All PCRs were carried out using the following
protocol: denaturation at 94 °C for 2min, then 35 cycles each of 94 °C
30 s, TA °C 30 s and 72 °C 30 s, with a final extension step of 72 °C
10min.
Multiplex PCR was also performed, adapted from a protocol opti-
mised by Bisset et al. (2014). Briefly, each 12.5 μl reaction contained:
2.5 μl 5X GoTaq Green buffer, 1.25 μl MgCl2 25mM, 0.0625 μl GoTaq
Flexi polymerase 5 U/μl (Promega), 0.25 μl dNTPs 10mM each (NEB
Inc.), 0.15 μl Generic Forward primer 10 μM, 0.15 μl Generic Reverse
primer 10 μM, 0.25 μl Trichostrongylus axei Forward primer 10 μM,
0.35 μl Cooperia curticei Forward 3 primer 10 μM, 0.1 μl Oesophagos-
tomum venulosum Reverse 1 primer 10 μM, 0.15 μl Chabertia ovina For-
ward 2 primer 10 μM, (Eurofins Genomics) and 6.2875 μl DEPC treated
water (Ambion). To this 1 μl of diluted DNA lysate was added. Touch-
down PCR conditions were: denaturation at 94 °C for 2min, then 12
cycles each of 94 °C 15 s, 60 °C, decreasing by 0.5 °C each cycle, to
54.5 °C for 15 s and lastly 72 °C 30 s. Next, 25 cycles each of 94 °C 15 s,
54 °C 15 s, 72 °C 30 s, with a final extension step of 72 °C for 7min.
Products were visualised with SafeView (NBS Biologicals) on 2%
agarose gels for single species PCR and 2.5% agarose gels for multi-
plexed PCR.
Any unidentified strongyles (i.e. positive on the multiplex PCR as a
strongylid nematode) were amplified with Phusion High-Fidelity
Polymerase (NEB Inc.) using the generic ITS2 primer set (Bisset et al.,
2014) and sequenced by Eurofins Genomics. A BLAST search using
NCBI was performed for identification. Speciation results were analysed
in Microsoft Excel and proportions of each species, determined by PCR,
were used to estimate individual T. circumcincta egg counts pre- and
post-treatment. A 2-sample proportion test was performed in Minitab to
compare speciation results pre- and post-treatment.
2.4.3. Pyrosequencing
Using a method adapted from Skuce et al. (2010), BZ resistance
associated SNPs were pyrosequenced in 30 T. circumcincta individuals
from each sampling time point (eggs, L1 or L3, as described in 2.4.1),
providing a total of 180 individuals for analysis. As for the speciation
PCRs, on days 0 and 7 of each FECRT, 30 L3 were selected, but on day
14 post-treatment for each FECRT, a combination of eggs and L1 were
used, totalling 30 individuals. Two regions of the β-tubulin isotype-
1 gene (one region including codons 200 and 198, and the other in-
cluding codon 167) were amplified using the Pyromark PCR kit
(Qiagen) according to the manufacturer’s instructions. Briefly, a 25 μl
reaction was set up using 12.5 μl 2X Pyromark Master Mix, 0.5 μl of
each primer, 10.5 μl DEPC treated water (Ambion) and 1 μl of diluted
DNA lysate. PCR conditions were: denaturation at 95 °C for 15min,
then 45 cycles of 94 °C for 30 s, 55 °C for 30 s and 72 °C for 30 s, with a
final extension step of 72 °C for 10min. Pyrosequencing was performed
on a Biotage Q96 ID instrument (Qiagen) according to the manu-
facturer’s protocol with pyrograms evaluated manually. The sequences
analysed were; 200/198 ‘CAGWAYGTYDMRTCGG’ for codons F200Y
and E198 A/L, and ‘TCATWCTC’ for codon F167Y. Primers used are
shown in Table 2. A 2-sample proportion test was performed in Minitab
to compare pyrosequencing results pre- and post-treatments.
3. Results
3.1. FECRT indicates resistance to anthelmintics tested
The FECRTs for both BZ and IVM indicated the presence of an-
thelmintic resistance (Table 3). The BZ treated lambs showed a reduc-
tion of 65% (95% Highest Posterior Density (HPD) Interval: 14.5, 86.2)
in their strongyle faecal egg output at day 14 and the IVM group, a 77%
(95% HPD Interval: 45.5, 91.6) reduction in faecal egg output.
3.2. Speciation allows interpretation of the FEC by species of interest
Speciation by PCR of ≤ 96 strongyle eggs or larvae was performed
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both pre- and post-treatment. Samples analysed from both groups of
lambs contained between 20 to 25% T. circumcincta pre-treatment with
the remaining 75 to 80% composed of a diverse mix of other strongyle
species (Figs. 1 and 2). In faecal samples from the BZ treated lambs,
both T. circumcincta and C. curticei were present at 7 days post-treat-
ment, in roughly equal proportions. By day 14 post-treatment, the
strongyle population post-BZ was composed of 88% T. circumcincta with
the remaining 12% comprising a mixture of C. curticei, O. venulosum and
T. axei (Fig. 1). In contrast, post-IVM treatment only T. circumcincta was
present at day 7 and at day 14 (Fig. 2).
3.3. Adjustment of the mean FEC by species improves interpretation of the
FECRT
An adjustment of the mean FEC by PCR speciation data shows a
decrease of approximately 50% in the T. circumcincta egg output, and
an 82% reduction in C. curticei egg output on day 7 following BZ
treatment (Fig. 3). No other species were found at day 7 post-BZ
treatment. On day 14 post-BZ treatment, T. circumcincta egg output had
risen considerably relative to day 0, being estimated at 67 epg by
speciation. This was not, however, statistically significant. C. curticei
epg had fallen to 5 epg from an initial 148 epg on day 0. Overall, there
was a significant reduction in egg output from strongyle species other
than T. circumcincta (p= 0.00). Following IVM treatment on the same
farm there was no change in egg output for T. circumcincta, whilst the
egg output of all other species was reduced to zero (Fig. 4).
3.4. Phenotyping bioassays (TBZ EHT, IVM LDT)
An EHT (assessing BZ resistance) and a LDT (assessing IVM re-
sistance) were performed on days 0 and 14 to compare FECRT results
with in vitro phenotype.
Table 2
Primer sequences used in this study.
Species Primer name Sequence TA (°C) Label Product size (bp) Reference
Teladorsagia circumcincta Tc_ITS2 F: ATACCGCATGGTGTGTACGG 52 421 Burgess 2012
R: CAGGAACGTTACGACGGTAAT Burgess 2012
Trichostrongylus vitrinus Tv_ITS2 F: AGGAACATTAATGTCGTTACA 52 100 Wimmer 2004
R: CTGTTTGTCGAATGGTTATTA Wimmer 2004
Haemonchus contortus Hc_ITS2 F: GTTACAATTTCATAACATCACGT 50 321 Redman 2008
R: TTTACAGTTTGCAGAACTTA Redman 2008
Generic ITS2 ITS2GF F: CACGAATTGCAGACGCTTAG 54 370-398 Bisset 2014
Generic ITS2 ITS2GR R: GCTAAATGATATGCTTAAGTTCAGC 54 Bisset 2014
Trichostrongylus axei TraxFd2 F: GATGTTAATGTTGAACGACATTAATATC 52 186 Bisset 2014
Chabertia ovina ChovFd2 F: CAGCGACTAAGAATGCTTTGG 54 115/117 Bisset 2014
Cooperia curticei CocuFd3 F: TAATGGCATTTGTCTACATTGGTTC 53 252 Bisset 2014
Oesophagostomum venulosum OeveRv1 R: CGACTACGGTTGTCTCATTTCA 54 323-329 Bisset 2014
Teladorsagia circumcincta Btub_SK_200_FOR F: ACCTTACAATGCCACTCTTTCTG 55 Biotin 97 Skuce 2010
Teladorsagia circumcincta Btub_SK_200_REV R: GCGGAAGCAGATATCGTACAG 55 Skuce 2010
Teladorsagia circumcincta Btub_SK_200_SEQ SEQ: RGAGCYTCATTATCGATR Skuce 2010
Teladorsagia circumcincta Btub_SK_167_FOR GCATTCTTTGGGAGGAGGTA 55 122 Skuce 2010
Teladorsagia circumcincta Btub_SK_167_REV TGCACCTCGAGAACCTGTACATA 55 Biotin Skuce 2010
Teladorsagia circumcincta Btub_SK_167_SEQ CGGATAGAATCATGGCT Skuce 2010
Table 3
Benzimidazole and ivermectin faecal egg count reduction tests. Arithmetic mean strongyle egg counts and proportional Teladorsagia circumcincta egg counts (adjusted
by species percentage as determined by PCR) are reported, with strongyle faecal egg count reduction percentages for each anthelmintic. The benzimidazole faecal egg
count reduction percentage has been calculated for both T. circumcincta and Cooperia curticei but only for T. circumcincta post ivermectin treatment as all other species
egg counts were zero on day 14 post-ivermectin.
Sample ID Na Mean
Strongyle
epgb
SD
Strongyle
epg
Mann-Whitney test
Strongyle epgc
Proportional T.
circumcincta
Mean epgd
SD T.
circumcincta
epg
Mann-Whitney test T.
circumcincta epgb
Strongyle
FECR %
(Bayesian
95 % HPDe
Interval)f
Teladorsagia
circumcincta
FECR %
(Bayesian 95
% HPD
Interval) d
Cooperia
curticei
FECR %
(Bayesian
95 % HPD
Interval)d
D7 D14 D7 D14
BZ D0 10 209 182 p=0.005 p=0.005 41.3 36 p=0.056 p=0.212 – – –
BZ D7 8 47.1 75.4 – p=0.534 21.3 34 – p=0.625 – – –
BZ D14 10 77 156 – – 67 137 – – 65.3
(14.5, 86.2)
4.99
(0.0, 55.8)
91.8
(82.4, 96.1)
IVM D0 12 202 186 p=0.003 p=0.002 51 47 p=0.976 p=0.583 – – –
IVM D7 11 53.8 53.6 – p=0.666 53.8 53.6 – p=0.666 – – –
IVM D14 12 48.4 57.9 – – 48.4 57.9 – – 77.2
(45.5, 91.6)
9.17
(0.0, 53.2)
–
aNumber of lambs sampled. Lambs were brought in from the field at each sampling time point by the farmer. On day 7 not all lambs were present or contained
sufficient material per rectum for an adequate sample to be obtained.
bEgg per gram.
cComparing egg count medians between sampling dates; p value reported. Ran ‘Difference = η (D0) – η (D14)’, 95% confidence intervals, hypothesis of ‘medians not
equal’ using Minitab. Numbers in bold indicate significant differences between sample medians.
dT. circumcincta epg calculated for each individual sample using the strongyle species proportions obtained from PCR of the ITS2 region of L3 (D0, D7) and eggs/L1
(D14).
eHighest posterior density interval.
fFECR percentage calculated using R shiny ‘eggCounts’, reported HPD.Low, mode and HPD.High as most accurate estimates. Bayesian CI (HPD.Low and HPD.High)
are in brackets.
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3.4.1. Egg hatch test
Pre-BZ treatment 79% of eggs hatched in control wells compared to
91% post-BZ treatment (Supplementary Table 1). Just 39% of eggs from
the pre-BZ treatment sample hatched in the TBZ EHT at the definitive
dose of 0.1 μg/ml (Coles et al., 2006), while post-BZ treatment, 93%
hatched (Table 4), giving a resistance ratio of 2.4 (% hatch post-treat-
ment/% hatch pre-treatment). Calculating the ED50 also revealed a
difference pre- and post-BZ treatment, with 50% hatching at a higher
concentration of TBZ/DMSO post-treatment (0.615 μg/ml) compared
with pre-treatment (0.048 μg/ml) (Table 4, Fig. 5), giving a resistance
ratio of 12.8 (ED50 post-treatment/ED50 pre-treatment).
While a full EHT was not carried out for pre- and post-IVM samples,
33% of eggs in the pre-IVM treatment population hatched at 0.1 μg/ml
TBZ and an ED50 of 0.043 μg/ml was calculated, comparable to the pre-
BZ FECRT EHTs (Table 4 and Supplementary Fig. 1). Post-IVM treat-
ment only two replicates of 0.1 μg/ml TBZ were set up, in which 82%
eggs hatched, suggesting a resistance ratio of 3.0 at the definitive dose
(raw data used, Table 4). This initially surprising result was illuminated
by the inclusion of speciation and pyrosequencing data (section 3.5),
which revealed that this apparent selection for BZ resistance by IVM
instead reflected the presence of a highly dual-resistant T. circumcincta
population.
3.4.2. Larval development test
Average egg hatch in the 2% DMSO control wells of the LDT was
97%. Pre-treatment 67% of hatched larvae developed to L3 on average
(range 53–75%), compared to 86% post-IVM treatment (Supplementary
Table 2). No definitive dose has been established for the IVM LDT used
in our study, but using a GLM, the ED50 can be determined. Pre-IVM
treatment this was 2.43 nM (95% CI: 2.14, 2.81) and post-IVM treat-
ment this rose to 4.07 nM (95% CI: 2.87, 6.36) (Table 5 and Fig. 6),
giving a resistance ratio of 1.7. Pre-BZ treatment an ED50 of 2.27 nM
was calculated, comparable to that of the pre-IVM group (Table 5 and
Supplementary Fig. 2).
3.5. Pyrosequencing of the T. circumcincta β-tubulin isotype-1 gene reveals
a diverse range of resistance alleles
Previous studies have identified mutations in three codons within
the β-tubulin isotype-1 gene that are correlated with BZ resistance
Fig. 1. Benzimidazole faecal egg count reduction test: strongyle species per-
centages. Numbers speciated by PCR: 96 Pre-BZ, 62 day 7 Post-BZ and 82 day
14 Post-BZ. Species identified: Oesophagostomum venulosum, Cooperia curticei,
Chabertia ovina, Trichostrongylus axei, Trichostrongylus vitrinus, Teladorsagia cir-
cumcincta.
Fig. 2. Ivermectin faecal egg count reduction test: strongyle species percen-
tages. Numbers speciated by PCR: 83 Pre-IVM, 83 day 7 Post-IVM and 42 day
14 Post-IVM. Species identified: Oesophagostomum venulosum, Cooperia curticei,
Chabertia ovina, Trichostrongylus axei, Trichostrongylus vitrinus, Teladorsagia cir-
cumcincta.
Fig. 3. Benzimidazole faecal egg count reduction test: arithmetic mean stron-
gyle egg per gram adjusted by species percentage. Mean strongyle faecal egg
counts were adjusted proportionally based on the strongyle species percentage
data as determined by PCR. SEM bars are displayed. Species identified:
Oesophagostomum venulosum, Cooperia curticei, Chabertia ovina, Trichostrongylus
axei, Trichostrongylus vitrinus, Teladorsagia circumcincta.
Fig. 4. Ivermectin faecal egg count reduction test: arithmetic mean strongyle
egg per gram adjusted by species percentage. Mean strongyle faecal egg counts
were adjusted proportionally based on the strongyle species percentage data as
determined by PCR. SEM bars are displayed. Species identified:
Oesophagostomum venulosum, Cooperia curticei, Chabertia ovina, Trichostrongylus
axei, Trichostrongylus vitrinus, Teladorsagia circumcincta.
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(F200Y, E198 A/L, F167Y) (Kwa et al., 1995; Barrère et al., 2012; Kotze
et al., 2012). In total, 180 individual T. circumcincta from all FECRT
sample populations (30 individuals from each sampling time-point)
were pyrosequenced at all three codons (Figs. 7 and 8). Of these, 168
were either homozygous or heterozygous for the resistance mutation at
codon 200. In total, seven different allelic sequences were identified in
the 123 individuals homozygous for this mutation. Individuals that
were heterozygous at one or more resistance-associated codons were
also detected at all sampling time points of both the BZ and IVM FECRT.
Those with homozygous resistance mutations at codon 198 (P200 F,
P198 L, P167 F) were detected on day 0 of the IVM FECRT and on days
7 and 14 of the BZ FECRT. All larvae with resistance-associated poly-
morphisms at codon 198 encoded leucine rather than alanine. No in-
dividuals with homozygous resistance mutations at codon 167 were
identified, nor were any individuals identified with mutations at other
Table 4
Egg hatch test results: Effective doses (ED50) of thiabendazole required to
prevent hatching of 50% of eggs are reported for each full assay performed. The
average percentage hatch in definitive dose wells (0.1 μg/ml) is given for each
assay.
Assay EHT ED50 (μg/
ml)a
Percentage hatch in
0.1 μg/mlb
Pre-BZ FECRT (four plates
combined analysis)
0.048
(0.045, 0.052)
39.1%
(8.58)
Post-BZ FECRT 0.615
(0.538, 0.730)
93.1%
(0.23)
Pre-IVM FECRT (four plates
combined analysis)
0.043
(0.040, 0.046)
32.6%
(6.06)
Post-IVM FECRT – 82.4%c
(3.43)
aRaw data was adjusted for response in 0.5% DMSO control wells. 95% con-
fidence intervals reported in brackets.
bAdjusted for response in 0.5% DMSO control wells. Standard deviation re-
ported in brackets.
cNo DMSO well was included post-IVM treatment and only two replicate wells
for 0.1 μg/ml were included. This therefore is the uncorrected percentage
hatch. The uncorrected percentage hatch in the 0.1 μg/ml wells pre-IVM
treatment was 27.52% (5.0 standard deviation).
Fig. 5. Egg hatch test: pre- and post-benzimidazole faecal egg count reduction
test. The corrected EHT data is shown, with log10(thiabendazole concentration)
plotted against the proportion hatching. The data was modelled in R using a
binomial GLM (probit), and the regression line is plotted here.
Table 5
Ivermectin larval development tests. Effective doses (ED50) of ivermectin re-
quired to inhibit 50% development of eggs to L3 are reported for each assay
performed.
Assay IVM LDT ED50 (nM)a
Pre-BZ FECRT (two plates combined analysis) 2.27
(2.05, 2.56)
Pre-IVM FECRT (two plates combined analysis) 2.43
(2.14, 2.81)
Post-IVM FECRT 4.07
(2.87, 6.36)
a Raw data was adjusted for response in 2% DMSO control wells. 95% con-
fidence intervals reported in brackets.
Fig. 6. Larval development test: pre- and post-ivermectin faecal egg count re-
duction test. The corrected LDT data is shown, with log10(ivermectin con-
centration) plotted against the proportion developing to L3. The data was
modelled in R using a binomial GLM (probit), and the regression line is plotted
here.
Fig. 7. Benzimidazole faecal egg count reduction test: pyrosequenced geno-
types of β-tubulin isotype-1. Thirty T. circumcincta individuals were sequenced
at each sampling time point at codons 167, 198 and 200 of the β-tubulin iso-
type-1 gene.
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codons if homozygous resistance mutations were present at either
codon 198 or 200. Individuals with homozygous susceptible genotypes
were identified (genotype P200 F, P198E and P167 F) on days 0, 7 and
14 of the IVM FECRT and on day 14 of the BZ FECRT (Figs. 7 and 8). For
both the BZ and IVM treatment groups no significant differences in
genotype proportions were noted between samples before and after
treatment (Figs. 7 and 8).
4. Discussion
The results presented in this paper provide evidence of a dual-re-
sistant T. circumcincta population on a commercial farm and highlight
the importance of speciation for the valid interpretation of FECRTs.
Group mean FECs reduced following both BZ and IVM treatments, by
65% and 77% respectively, suggesting that both IVM and BZ retained
some activity on the farm in question. However, extrapolation of the
strongyle FEC by individual species revealed that, despite a significant
reduction in total FEC post-treatment (p < 0.01), there was no sig-
nificant change in the egg output of T. circumcincta, the primary pa-
thogen causing PGE, following either treatment. The clinical inter-
pretation of this full FECRT is therefore very different to a statistical one
based on FECs alone. While high BZ and IVM resistance would be sig-
nificant on any sheep farm, in this flock, there is also levamisole and
moxidectin resistance diagnosed by FECRT (data not shown), leaving
the shepherd with very few options for chemotherapeutic control of the
nematode population. In this instance an anthelmintic, though< 95%
effective, might still be employed as part of a flock health plan to
control PGE.
PCR speciation of L3 larvae revealed a diverse mix of strongyle
species pre-treatment, a situation not uncommon in the UK (Burgess
et al., 2012; Redman et al., 2015). Species diversity may be supported
on this farm for several reasons. Firstly, it is an openly managed flock,
which may allow influx of new species over time. Previous studies in
France have found links between increased species diversity and the
number of farms originally contributing to a subsequently closed herd
(Silvestre et al., 2000). There are a variety of grazing areas on the farm,
including short grass pasture, longer grassy areas containing other weed
species and woodland. These may favour micro-niches for parasite
species, encouraging diversity (Sinclair et al., 2016). Sheep groups
move between pastures and rams rotate between both pastures and
sheep groups enabling further mixing of the parasite communities. In
addition, cattle have previously grazed on farm pastures, though not in
the last two years, a practice that has been shown to increase species
diversity on irrigated pasture in the tropics (Giudici et al., 1999). Lastly,
the farm is moderate in area, being only about 60 ha, enabling frequent
grazing of all pastures, which has been linked in other studies with
increased species diversity, due in part to the ability of rarer species
with longer pre-patent periods and shorter pasture survival times to be
effectively maintained within the flock (Silvestre et al., 2000).
Several species, namely C. curticei, O. venulosum and T. axei, were
also found to be present post-BZ treatment in addition to T. cir-
cumcincta. This suggests some level of resistance within these popula-
tions, consistent with previous studies (Hunt et al., 1992; Moreno et al.,
2004; Palcy et al., 2010; Keegan et al., 2017). In contrast to the BZ
FECRT, only T. circumcincta was detected post-IVM treatment, sug-
gesting that other strongyle species present on the farm are susceptible
to IVM, despite apparent resistance to BZ. The pattern of anthelmintic
usage on the farm over the year may impact resistance development
following treatment with BZ or IVM. BZ anthelmintics were routinely
used several times in the spring to control N. battus, at a time point
when pasture larvae are predominantly present from overwintered
survival (Gibson and Everett, 1972), lamb strongyle FECs were minimal
and species prevalence diversity was low within the lambs (being
principally T. circumcincta, data not shown). At this time, and with
monthly dosing treatment, BZ resistance may be more efficiently se-
lected within the different species populations due to the smaller pas-
ture population in refugia (Martin et al., 1981). In comparison, IVM is
used for the most part in late summer, when pasture larval levels are
higher and egg counts greater. Any resistant species surviving at this
time would need to be present in sufficient numbers within the host, to
prevent dilution of resistant alleles by susceptible larvae ingested from
pasture. Perhaps more importantly for IVM resistance development,
routine use of oral moxidectin on this farm at lambing time may have
influenced the IVM phenotype of the T. circumcincta population. The
persistent effect of moxidectin prevents establishment by H. contortus
and T. circumcincta larvae for up to five weeks post-treatment (Kerboeuf
et al., 1995), but it does not target immature larvae of other species
(Zoetis product datasheet, Cydectin ® 0.1% w/v oral solution), de-
creasing the macrocyclic lactone selection pressure on the wider
strongyle community.
The FECRT was followed up using two additional tests of pheno-
typic resistance: an EHT for BZ resistance and a LDT for IVM. The EHT
has been studied extensively using laboratory isolates of various spe-
cies, and has also been utilised in some field studies (Calvete et al.,
2014). An EHT differentiates between resistant and susceptible popu-
lations by the known ability of TBZ to prevent hatching of BZ suscep-
tible eggs (Le Jambre, 1976). The EHT results reported in this study
were consistent with the FECRT data. By comparing the ED50 of the pre-
and post-BZ treatment assays, a considerable increase was noted in the
concentration at which 50% of the eggs failed to hatch, from 0.048 μg/
ml to 0.615 μg/ml TBZ. Although a full EHT was not carried out post-
IVM, a three-fold increase was observed in the percentage hatch in the
wells containing 0.1 μg/ml TBZ, following in vivo IVM treatment, sug-
gesting a dual-resistant population. Following ring testing of the EHT,
von Samson-Himmelstjerna et al (2009) suggested that the presence of
a resistant sub-population might be detected by recording the percen-
tage hatch in the 0.2 and 0.3 μg/ml wells. Interestingly, in our pre-
treatment EHTs we noted 31% and 24% egg hatch at these concentra-
tions respectively, similar percentages to the proportion of T. cir-
cumcincta represented.
In contrast, the LDT was less informative, possibly related to the
small number of replicates used in the post-IVM test. Although each of
the pre-FECRT LDTs were comparable with each other, suggesting the
LDT was repeatable, the fold-change post-IVM treatment was small (RR:
1.7). Two controls were used in the LDT; 2% DMSO and deionised
water. Despite hatching of almost all eggs, development to L3 in the 2%
DMSO control wells could be as low as 53%, with higher levels of de-
velopment recorded in the water wells. However, these results are si-
milar to others reported in the literature: rates of larval development
varied from 64 to 86% for the L3 of Oesophagostomum species in 6%
Fig. 8. Ivermectin faecal egg count reduction test: pyrosequenced genotypes of
β-tubulin isotype-1. Thirty T. circumcincta individuals were sequenced at each
sampling time point at codons 167, 198 and 200 of the β-tubulin isotype-1 gene.
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DMSO control wells (Varady et al., 1996) and from 58 to 89% for H.
contortus, in control wells containing no DMSO (Heim et al., 2015). The
use of a micro agar LDT, rather than a liquid based assay, is reported to
support higher levels of development, ranging from 85 to 95% (Demeler
et al., 2013; Gill et al., 1995). However, in the present study, up to 86%
of eggs were capable of developing to L3 post-IVM treatment in the 2%
DMSO control wells, suggesting variation in rates of development also
reflects the mixed species present (Calvete et al., 2014). A similar dif-
ference was also noted in the 0.5% DMSO control wells of the EHT, with
a lower hatch rate pre-BZ treatment compared with post-BZ treatment.
Pyrosequencing of the three BZ resistance associated codons of the
β-tubulin isotype-1 gene (200, 198 and 167), found no significant dif-
ferences between sampling time points in the BZ or IVM treated T.
circumcincta populations. The numbers of individuals genotyped at each
sampling time point was small compared with the effective population
size, and this may explain the appearance of genotypes on days 7 and
14 which were not noted on day 0, including individuals with resistance
associated polymorphisms at codon 198.
The pre-BZ treatment sample had a high frequency (∼73%) of re-
sistance-associated mutations. BZ resistance is thought to be a recessive
trait in H. contortus (Kwa et al., 1995), and in a previous study, no H.
contortus adults that were heterozygous for the resistance mutation at
codon 200 (with susceptible genotypes at codons 198 and 167) were
found post-albendazole treatment (Barrère et al., 2012). In this study,
we genoyped the offspring of T. circumcincta adult survivors, and in
contrast to Kwa et al (1995), detected the presence of individuals with
fully susceptible genotypes post-BZ treatment. This suggests that T.
circumcincta adults that are heterozygous for resistance mutations have
survived to produce offspring with susceptible genotypes. Consistent
with our findings, a study by Keegan et al. (2017), in Ireland, found T.
circumcincta adults surviving oxfendazole treatment which were het-
erozygous at codon 200 alone (P200 F/Y, P198E, P167 F). Interestingly,
they also identified individuals with fully susceptible genotypes, con-
sistent with the presence of an additional BZ resistance locus, which
could explain the differences in heterozygote survival described above.
Post-BZ treatment the increase in individuals with resistance asso-
ciated polymorphisms at codon 198, indicates that these genotypes
were selected by BZ treatment in addition to resistance associated
mutations at codons 200 and 167. Interestingly, a combined EHT/LDT
using H. contortus, suggested that, in larval stages at least, individuals
with resistance associated polymorphisms at codon 198 (P198 A)
showed a higher level of resistance to TBZ than those with poly-
morphisms at codon 200 (P200Y) (Kotze et al., 2012). It is thought that
individuals cannot carry more than one BZ-resistance associated mu-
tation on the same haplotype at either position 200, 198 or 167 as this
may be a lethal genotype (Barrère et al., 2012). While pyrosequencing
does not provide any haplotypic data, analysis of 180 individuals in this
project did not detect any larvae carrying more than two BZ resistance-
associated SNPs, suggestive of no more than one resistant codon per
allele. Post-IVM treatment, offspring of surviving adults share the same
genotypes as those sequenced following BZ treatment, including those
which are homozygous resistant at codon 200 indicating the presence of
a dual-IVM and BZ resistant T. circumcincta population on the farm.
Guidelines are available in the UK to assist farmers in reducing
worm burden and controlling PGE in their flocks (Abbott et al., 2012).
These are continually reviewed and updated based on current evidence
with a view to increasing production efficiency, improving welfare, and
reducing the rate of development of resistance (Learmount et al., 2015).
Currently, molecular markers are available for BZ resistance (Kwa et al.,
1995; Silvestre and Cabaret, 2002; Ghisi et al., 2007; Redman et al.,
2015), and markers are being further characterised for levamisole re-
sistance (Boulin et al., 2011; Barrère et al., 2014). It is possible to use
the BZ resistance genetic markers to assess the presence and origin of
resistance in field populations (Redman et al., 2015), but little is known
about IVM resistance, which is thought to be polygenic (Kotze et al.,
2014). Modern methods of parasite speciation such as the nemabiome
(Avramenko et al., 2017) and multiplex tandem PCR (Roeber et al.,
2017) offer promise for the future diagnosis of anthelmintic resistant
worms. However, until the use of such molecular tools becomes wide-
spread, FECRT will continue to provide a useful measure of drug effi-
cacy, but in the absence of species prevalence data, must be interpreted
with care. The presence of a dual-resistant T. circumcincta population on
this farm indicates that the use of either anthelmintic will preferentially
select for this pathogenic species, and that combination treatments of
BZ and IVM, or rotation of anthelmintic classes may not be beneficial
for this flock.
5. Conclusion
This study clearly demonstrates the complicating factors of stron-
gyle species diversity in field populations when interpreting a FECRT.
We would therefore encourage the routine speciation of strongyles
obtained during both pre- and post-treatment FEC samples, for optimal
interpretation of the results, with the additional testing of a combina-
tion of products for each group of lambs used in the FECRT to enable
detection of dual-resistant species. Pyrosequencing gave additional in-
formation but would be unlikely to provide significant insight to a
farmer in practice except in the early stages of BZ resistance (e.g. for N.
battus (Morrison et al., 2014)); however, pyrosequencing would be
useful for monitoring management strategies in the research setting, or
if a BZ drench was not used during the FECRT.
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